Literature DB >> 8922304

Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.

K A Rosenblatt1, D B Thomas.   

Abstract

Possible relationships between tubal ligation and hysterectomy and epithelial ovarian cancer were assessed in data that were collected for a multinational hospital-based case-control study conducted between 1979 and 1988. Histologically confirmed incident cases (n = 393) were compared with controls (n = 2563) matched on age, hospital, and year of interview. A nonsignificant reduction in risk was observed for tubal ligation [odds ratio (OR), 0.72; 95% confidence interval (CI), 0.48-1.08] and hysterectomy (OR, 0.58; 95% CI, 0.26-1.27). There was no trend in risk with time since tubal ligation. The possible protective effect of tubal ligation was greatest in women of parity less than four. The apparent protective effect of tubal ligation was seen only for clear cell (OR, 0.32; 95% CI, 0.006-2.50) and endometrioid (OR, 0.20; 95% CI, 0.046-1.46) tumors, suggesting a hormonal mechanism for the observed associations.

Entities:  

Keywords:  Cancer; Case Control Studies; Diseases; Family Planning; Female Sterilization; Gynecologic Surgery; Hysterectomy; Neoplasms; Ovarian Cancer; Research Methodology; Research Report; Sterilization, Sexual; Studies; Surgery; Treatment; Tubal Ligation--beneficial effects; Tubal Occlusion; Urogenital Surgery

Mesh:

Year:  1996        PMID: 8922304

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

1.  Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.

Authors:  Nonna V Kolomeyevskaya; J Brian Szender; Gary Zirpoli; Albina Minlikeeva; Grace Friel; Rikki A Cannioto; Rachel M Brightwell; Kassondra S Grzankowski; Kirsten B Moysich
Journal:  Int J Gynecol Cancer       Date:  2015-11       Impact factor: 3.437

2.  Recommendations for the reporting of fallopian tube neoplasms.

Authors:  Teri A Longacre; Esther Oliva; Robert A Soslow
Journal:  Virchows Arch       Date:  2006-11-25       Impact factor: 4.064

3.  Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer.

Authors:  Thomas A Sellers; Yifan Huang; Julie Cunningham; Ellen L Goode; Rebecca Sutphen; Robert A Vierkant; Linda E Kelemen; Zachary S Fredericksen; Mark Liebow; V Shane Pankratz; Lynn C Hartmann; Jeff Myer; Edwin S Iversen; Joellen M Schildkraut; Catherine Phelan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

4.  Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.

Authors:  Megan S Rice; Megan A Murphy; Allison F Vitonis; Daniel W Cramer; Linda J Titus; Shelley S Tworoger; Kathryn L Terry
Journal:  Int J Cancer       Date:  2013-07-09       Impact factor: 7.396

5.  The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

Review 6.  Precursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update.

Authors:  Felix Zeppernick; Ivo Meinhold-Heerlein; Ie-Ming Shih
Journal:  J Obstet Gynaecol Res       Date:  2014-10-20       Impact factor: 1.730

7.  Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.

Authors:  Lauren C Peres; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Ann G Schwartz; Paul D Terry; Sarah E Abbott; Fabian Camacho; Frances Wang; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

Review 8.  Origin of ovarian cancer: molecular profiling.

Authors:  Dilip Kumar Dutta; Indranil Dutta
Journal:  J Obstet Gynaecol India       Date:  2013-06-21

9.  A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.

Authors:  Mark H Greene; Marion Piedmonte; Dave Alberts; Mitchell Gail; Martee Hensley; Zoe Miner; Phuong L Mai; Jennifer Loud; Gustavo Rodriguez; Jack Basil; John Boggess; Peter E Schwartz; Joseph L Kelley; Katie E Wakeley; Lori Minasian; Stephen Skates
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

10.  Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas.

Authors:  Chi-An Chen; Ying-Cheng Chiang; Ming-Cheng Chang; Yu-Hao Hu; San-Lin You; Yeu-Yao Kevin Cheng; Cheng-Yang Chou; Wen-Fang Cheng
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.